Association between secondary mutations in human immunodeficiency virus type 1 protease and therapeutic outcome.
Frater
John
J
Dunn
David
D
Weber
Jonathan N
JN
McClure
Myra O
MO
D019380:Anti-HIV Agents / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D016333:HIV Protease / Q000235:genetics*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage*; D009154:Mutation; D016896:Treatment Outcome
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D016333:HIV Protease